Biohub have launched a new AI-powered biology initiative, aiming to accelerate scientific discovery and drug development.

Explore the role of IL-2 and GLP-1 receptor in neuroinflammation and their impact on neurodegenerative diseases.

Explore drug development for obesity and its focus on long-term weight management beyond just rapid loss for effective ...

Learn how artificial intelligence is used to design AI antibodies, marking a milestone in protein design and treatment innovation.

Learn about the advancements showcased at ELRIG’s Drug Discovery 2025. Discover practical solutions for modern drug research.

Explore how Alzheimer's fat tissue affects metabolism and contributes to heart and metabolic disorders in groundbreaking ...

Explore RNA folding and its significance in RNA-based therapeutics. Discover new insights from Japanese researchers on RNA ...

Nuclera partnership with Solve Scientific enhances access to the eProtein Discovery platform in Australia and New Zealand.

A newly developed peptide, WRPRFa, is giving scientists a clearer view of how the acid-sensing ion channel (ASIC3) drives ...

Explore the link between Alzheimer's progression and the enzyme biliverdin reductase A, which protects neurons from stress.

Learn how FSP1 protein helps metastatic melanoma cells survive and its potential in developing new cancer therapies.

Explore stroke and preeclampsia treatment advancements with DiaMedica's lead drug candidate DM199 and its impact on vascular ...